Besides, BsAbs such as AFM13 can crosslink the cancer antigen CD30 on tumor cells with CD16a on natural killer (NK) cells, rerouting NK cells to the tumor cells for lysing by antibody-dependent cellular cytotoxicity (ADCC) (3). Here, FCGR3A is linked to neoplasm.